Oxford-AstraZeneca COVID-19 vaccine produces strong immune responses in older adults

A COVID-19 vaccine from Oxford University and AstraZeneca in late-stage trials is found to be well tolerated, and produced a strong immune response in people over age 70, according to findings published in the Lancet.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

Hometown Heroes in New York City

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines